secwatch.observer — SEC 8-K summary
======================================

Issuer:     Theravance Biopharma, Inc. (TBPH)
CIK:        0001583107
Form:       8-K
Filed at:   2023-03-13T23:59:59+00:00
Accession:  0001104659-23-031420
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 7.01
LLM model:  deepseek-v4-flash:cloud@v2

Theravance Biopharma confirms zero exposure to Silicon Valley Bank
------------------------------------------------------------------

- Company states it holds no cash deposits or securities at Silicon Valley Bank.
- Disclosure addresses potential investor concerns about SVB's March 2023 collapse.
- No financial impact or operational disruption related to SVB's failure.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1583107/000110465923031420/0001104659-23-031420-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1583107/000110465923031420/tm239223d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-031420

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer